Lung cancer predictive biomarker testing is essential to select advanced-stage patients for targeted treatments and should be carried out without delays even during health emergencies, such as the coronavirus (COVID-19) outbreak.
Predictive molecular pathology in the time of coronavirus disease (COVID-19) in Europe
Fassan, Matteo;
2020
Abstract
Lung cancer predictive biomarker testing is essential to select advanced-stage patients for targeted treatments and should be carried out without delays even during health emergencies, such as the coronavirus (COVID-19) outbreak.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
jclinpath-2020-206957.pdf
non disponibili
Tipologia:
Published (publisher's version)
Licenza:
Accesso privato - non pubblico
Dimensione
445.86 kB
Formato
Adobe PDF
|
445.86 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
